These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 16078265)
21. The prognostic value of cyclin D1, p53, and MDM2 protein expression in uveal melanoma. Coupland SE; Anastassiou G; Stang A; Schilling H; Anagnostopoulos I; Bornfeld N; Stein H J Pathol; 2000 Jun; 191(2):120-6. PubMed ID: 10861569 [TBL] [Abstract][Full Text] [Related]
22. Proliferative activities in conventional chordoma: a clinicopathologic, DNA flow cytometric, and immunohistochemical analysis of 17 specimens with special reference to anaplastic chordoma showing a diffuse proliferation and nuclear atypia. Naka T; Fukuda T; Chuman H; Iwamoto Y; Sugioka Y; Fukui M; Tsuneyoshi M Hum Pathol; 1996 Apr; 27(4):381-8. PubMed ID: 8617482 [TBL] [Abstract][Full Text] [Related]
23. Prognostic relevance of histologic grading, the cell cycle-associated antigen Ki-S1 and cell cycle regulators in malignant fibrous histiocytomas: a multivariate analysis. Brinck U; Cordon-Cardo C; Korabiowska M; Kellner S; Trybus-Galuszka H; Stachura J; Parwaresch MR; Schauer A Verh Dtsch Ges Pathol; 1998; 82():232-8. PubMed ID: 10095440 [TBL] [Abstract][Full Text] [Related]
24. Apoptotic and proliferative markers in chordomas: a study of 26 tumors. Kilgore S; Prayson RA Ann Diagn Pathol; 2002 Aug; 6(4):222-8. PubMed ID: 12170453 [TBL] [Abstract][Full Text] [Related]
25. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors. Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733 [TBL] [Abstract][Full Text] [Related]
26. A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in soft-tissue sarcomas. Rieske P; Bartkowiak JK; Szadowska AM; Olborski B; Harezga-Bal B; Debiec-Rychter M J Exp Clin Cancer Res; 1999 Sep; 18(3):403-16. PubMed ID: 10606188 [TBL] [Abstract][Full Text] [Related]
27. p16/p14(ARF) cell cycle regulatory pathways in primary neuroblastoma: p16 expression is associated with advanced stage disease. Omura-Minamisawa M; Diccianni MB; Chang RC; Batova A; Bridgeman LJ; Schiff J; Cohn SL; London WB; Yu AL Clin Cancer Res; 2001 Nov; 7(11):3481-90. PubMed ID: 11705866 [TBL] [Abstract][Full Text] [Related]
28. An immunohistochemical study of p16, pRb, p21 and p53 proteins in human esophageal cancers. Kato H; Yoshikawa M; Fukai Y; Tajima K; Masuda N; Tsukada K; Kuwano H; Nakajima T Anticancer Res; 2000; 20(1A):345-9. PubMed ID: 10769678 [TBL] [Abstract][Full Text] [Related]
29. Prognostic value of Mdm2, p53 and p16 in patients with astrocytomas. Ranuncolo SM; Varela M; Morandi A; Lastiri J; Christiansen S; Bal de Kier Joffé E; Pallotta MG; Puricelli L J Neurooncol; 2004 Jun; 68(2):113-21. PubMed ID: 15218947 [TBL] [Abstract][Full Text] [Related]
31. Intralesional fibrous septum in chordoma: a clinicopathologic and immunohistochemical study of 122 lesions. Naka T; Boltze C; Kuester D; Samii A; Herold C; Ostertag H; Iwamoto Y; Oda Y; Tsuneyoshi M; Roessner A Am J Clin Pathol; 2005 Aug; 124(2):288-94. PubMed ID: 16040302 [TBL] [Abstract][Full Text] [Related]
32. Wild-type p53 overexpression and its correlation with MDM2 and p14ARF alterations: an alternative pathway to non-small-cell lung cancer. Wang YC; Lin RK; Tan YH; Chen JT; Chen CY; Wang YC J Clin Oncol; 2005 Jan; 23(1):154-64. PubMed ID: 15625370 [TBL] [Abstract][Full Text] [Related]
33. Mdm2 overexpression and p14(ARF) inactivation are two mutually exclusive events in primary human lung tumors. Eymin B; Gazzeri S; Brambilla C; Brambilla E Oncogene; 2002 Apr; 21(17):2750-61. PubMed ID: 11965548 [TBL] [Abstract][Full Text] [Related]
34. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1. Korkolopoulou P; Christodoulou P; Konstantinidou AE; Thomas-Tsagli E; Kapralos P; Davaris P Hum Pathol; 2000 Jun; 31(6):751-60. PubMed ID: 10872671 [TBL] [Abstract][Full Text] [Related]
35. The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer. Korkolopoulou P; Christodoulou P; Kapralos P; Exarchakos M; Bisbiroula A; Hadjiyannakis M; Georgountzos C; Thomas-Tsagli E Pathol Res Pract; 1997; 193(11-12):767-75. PubMed ID: 9521509 [TBL] [Abstract][Full Text] [Related]
36. Alterations of rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma. Soni S; Kaur J; Kumar A; Chakravarti N; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R Oncology; 2005; 68(4-6):314-25. PubMed ID: 16020958 [TBL] [Abstract][Full Text] [Related]
37. Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions. Ruggeri BA; Huang L; Berger D; Chang H; Klein-Szanto AJ; Goodrow T; Wood M; Obara T; Heath CW; Lynch H Cancer; 1997 Feb; 79(4):700-16. PubMed ID: 9024708 [TBL] [Abstract][Full Text] [Related]
38. Altered expression of the cell cycle regulatory molecules pRb, p53 and MDM2 exert a synergetic effect on tumor growth and chromosomal instability in non-small cell lung carcinomas (NSCLCs). Gorgoulis VG; Zacharatos P; Kotsinas A; Mariatos G; Liloglou T; Vogiatzi T; Foukas P; Rassidakis G; Garinis G; Ioannides T; Zoumpourlis V; Bramis J; Michail PO; Asimacopoulos PJ; Field JK; Kittas C Mol Med; 2000 Mar; 6(3):208-37. PubMed ID: 10965496 [TBL] [Abstract][Full Text] [Related]
39. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features. Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796 [TBL] [Abstract][Full Text] [Related]
40. CDK4 and MDM2 gene alterations mainly occur in highly proliferative and aggressive mantle cell lymphomas with wild-type INK4a/ARF locus. Hernández L; Beà S; Pinyol M; Ott G; Katzenberger T; Rosenwald A; Bosch F; López-Guillermo A; Delabie J; Colomer D; Montserrat E; Campo E Cancer Res; 2005 Mar; 65(6):2199-206. PubMed ID: 15781632 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]